118 related articles for article (PubMed ID: 9063524)
1. Isolated pelvic perfusion for the treatment of unresectable primary or recurrent rectal cancer.
Vaglini M; Cascinelli F; Chiti A; Deraco M; Inglese MG; Rebuffoni G; Rizzi M; Sala B; Santoro N; Santinami M
Tumori; 1996; 82(5):459-62. PubMed ID: 9063524
[TBL] [Abstract][Full Text] [Related]
2. Hypoxic pelvic perfusion with mitomycin C using a simplified balloon-occlusion technique in the treatment of patients with unresectable locally recurrent rectal cancer.
Guadagni S; Fiorentini G; Palumbo G; Valenti M; Russo F; Cantore M; Deraco M; Vaglini M; Amicucci G
Arch Surg; 2001 Jan; 136(1):105-12. PubMed ID: 11146790
[TBL] [Abstract][Full Text] [Related]
3. Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique.
Turk PS; Belliveau JF; Darnowski JW; Weinberg MC; Leenen L; Wanebo HJ
Arch Surg; 1993 May; 128(5):533-8; discussion 538-9. PubMed ID: 7683872
[TBL] [Abstract][Full Text] [Related]
4. Isolated chemotherapeutic perfusion of pelvis as neoadjuvant or palliative therapy for advanced cancer of the rectum.
Wanebo HJ; DiSiena M; Begossi G; Belliveau J; Gustafson E
Ann Surg Oncol; 2008 Apr; 15(4):1107-16. PubMed ID: 18157578
[TBL] [Abstract][Full Text] [Related]
5. Palliation with a multimodality treatment including hypoxic pelvic perfusion for unresectable recurrent rectal cancer: outcomes based on a retrospective study.
Guadagni S; Clementi M; Bencivenga M; Kusamura S; Fiorentini C; Masedu F
Updates Surg; 2018 Dec; 70(4):441-447. PubMed ID: 30191532
[TBL] [Abstract][Full Text] [Related]
6. Pelvic perfusion for locally recurrent unresectable rectal tumors.
Unal AE; Bayar S; Tez M; Gocmen E; Kocaoglu H; Akgul H
Hepatogastroenterology; 2005; 52(63):757-60. PubMed ID: 15966199
[TBL] [Abstract][Full Text] [Related]
7. Mitomycin C hypoxic pelvic perfusion for unresectable recurrent rectal cancer: pharmacokinetic comparison of surgical and percutaneous techniques.
Guadagni S; Fiorentini G; Clementi M; Palumbo P; Mambrini A; Masedu F
Updates Surg; 2017 Sep; 69(3):403-410. PubMed ID: 28791628
[TBL] [Abstract][Full Text] [Related]
8. Intra-arterial infusion chemotherapy in rectal cancer.
Duprat G; Chalaoui J; Sylvestre J; Simard P; Roy P; Potvin C; Cantin J; Robidoux A
Can J Surg; 1984 Jan; 27(1):57-9. PubMed ID: 6432303
[TBL] [Abstract][Full Text] [Related]
9. Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique.
Wanebo HJ; Chung MA; Levy AI; Turk PS; Vezeridis MP; Belliveau JF
Ann Surg Oncol; 1996 May; 3(3):295-303. PubMed ID: 8726186
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancer.
Guadagni S; Aigner KR; Palumbo G; Cantore M; Fiorentini G; Pozone T; Deraco M; Clerico M; Chaudhuri PK
J Clin Pharmacol; 1998 Oct; 38(10):936-44. PubMed ID: 9807975
[TBL] [Abstract][Full Text] [Related]
11. [Initial locoregional chemotherapy in recurrent and locoregional advanced or inoperable stages of pelvic uterine and anorectal cancers].
Manivit P; Polo R; Tabary D; Nabet M; Polo M; Adamy M; Rubini B; Fromaget JM; Chipponi PN; Untereiner M
Bull Cancer; 1995 Jan; 82(2):137-48. PubMed ID: 10846531
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer.
Anscher MS; Lee C; Hurwitz H; Tyler D; Prosnitz LR; Jowell P; Rosner G; Samulski T; Dewhirst MW
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):719-24. PubMed ID: 10837956
[TBL] [Abstract][Full Text] [Related]
13. Isolated chemotherapeutic perfusion of the pelvis for advanced rectal cancer.
Wanebo HJ; Belliveau J; Begossi G; Levy A
Colorectal Dis; 2003 Sep; 5(5):508-14. PubMed ID: 12925091
[TBL] [Abstract][Full Text] [Related]
14. Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers.
Strocchi E; Iaffaioli RV; Facchini G; Mantovani G; Ricci S; Cavallo G; Tortoriello A; D'Angelo R; Formato R; Rosato G; Fiore F; Iaccarino V; Petrella G; Memoli B; Santangelo M; Camaggi CM
Eur J Surg Oncol; 2004 Aug; 30(6):663-70. PubMed ID: 15256242
[TBL] [Abstract][Full Text] [Related]
15. Intraarterial chemotherapy and hyperthermia for pain control in patients with recurrent rectal cancer.
Estes NC; Morphis JG; Hornback NB; Jewell WR
Am J Surg; 1986 Dec; 152(6):597-601. PubMed ID: 3098128
[TBL] [Abstract][Full Text] [Related]
16. [Intra-arterial chemotherapy in inoperable and recurrent rectal tumors].
Andrysek O; Horák J; Vítek P
Bratisl Lek Listy; 1990 Apr; 91(4):289-91. PubMed ID: 2115813
[TBL] [Abstract][Full Text] [Related]
17. Mitomycin C, cisplatin, and 5-fluorouracil for advanced and/or recurrent head and neck squamous cell carcinomas.
Iop A; Cartei G; Vigevani E; Clocchiatti L; Mansutti M; Sibau AM
Am J Clin Oncol; 1997 Oct; 20(5):515-8. PubMed ID: 9345340
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic pelvic perfusion with cisplatin and mitomycin C in multidisciplinary palliative treatment of patients with unresectable recurrent rectal cancer: a retrospective study.
Guadagni S; Fiorentini G; Palumbo P; Masedu F; Ricevuto E; Bruera G; Deraco M; Kusamura S; Sarti D; Fiorentini C; Gailhofer S; Clementi M
Minerva Chir; 2019 Aug; 74(4):304-312. PubMed ID: 31062943
[TBL] [Abstract][Full Text] [Related]
19. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
20. [Antineoplastic perfusion with percutaneous stop-flow control in the treatment of advanced pelvic malignant neoplasms].
De Santis M; Ariosi P; Calò GF; Luppi G; Franchini M; Romagnoli R
Radiol Med; 2000; 100(1-2):56-61. PubMed ID: 11109453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
